HROW — HARROW, INC. catalysts
Next verified catalyst
2026-12-01 — A Phase 3 Study Evaluating the Safety and Efficacy of TRIESENCE® (Injectable Suspension) f · official source ↗
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-12 (month) in 2mo
ESTIMATED |
READOUT
A Phase 3 Study Evaluating the Safety and Efficacy of TRIESENCE® (Injectable Sus
Phase 3 · Postoperative Ocular Inflammation, Postoperative Ocular Pain |
HROW HARROW, INC. | TRIESENCE (triamcinolone acetonide injec |
ClinicalTrials.gov ↗
✓ Source-checked 2026-09-23
Sponsor-projected date — can change
|